• Skip to primary navigation
  • Skip to main content
SRI logo
  • About
    • Press room
    • Our history
  • Expertise
    • Advanced imaging systems
    • Artificial intelligence
    • Biomedical R&D services
    • Biomedical sciences
    • Computer vision
    • Cyber & formal methods
    • Education and learning
    • Innovation strategy and policy
    • National security
    • Ocean & space
    • Quantum
    • QED-C
    • Robotics, sensors & devices
    • Speech & natural language
    • Video test & measurement
  • Ventures
  • NSIC
  • Careers
  • Contact
  • 日本支社
Search
Close
Home » Pharmaceutical

Pharmaceutical

Return to the Timeline of innovation.

toxicity-lab-liver-sample
History of innovation November 17, 2021 Health, Pharmaceutical, The 1980s

Human liver tissue bank

SRI International

The first human liver tissue bank for testing drugs on humans versus animals.

History of innovation November 16, 2021 Federal programs, Health, Pharmaceutical, The 1950s

Cancer research

SRI International

SRI enters the ranks searching for possible anticancer agents–work that continues today.

History of innovation November 16, 2021 Firsts, Health, Pharmaceutical, Products, Seminal Innovations, The 1960s

Anti-viral: Vidarabine

SRI International

Drug originally intended to fight cancer discovered effective against herpes simplex and varicella zoster viruses.

mosquito
History of innovation November 16, 2021 Federal programs, Health, Military, Pharmaceutical, The 1960s

Malaria treatment: Halofantrine

SRI International

Treatment for drug-resistant malaria saves countless lives.

History of innovation November 16, 2021 Health, Pharmaceutical, Products, Seminal Innovations, The 1980s

Blood treatment: Hirudin

SRI International

New treatment for blood clot prevention stems from peptide once only found in leeches.

History of innovation November 16, 2021 Firsts, Health, Pharmaceutical, Products, Seminal Innovations, The 1990s

Lymphoma treatment: Targretin® (bexarotene)

SRI International

FDA approves treatment for cutaneous T-cell lymphoma.

History of innovation November 16, 2021 Health, Pharmaceutical, Products, The 2000s

Cancer treatment: Pralatrexate

SRI International

FDA approval of treatment for peripheral T-cell lymphoma caps decades of SRI research.

How can we help?

Once you hit send…

We’ll match your inquiry to the person who can best help you.

Expect a response within 48 hours.

Career call to action image

Make your own mark.

Search jobs

Our work

Case studies

Publications

Timeline of innovation

Areas of expertise

Institute

Leadership

Press room

Media inquiries

Compliance

Careers

Job listings

Contact

SRI Ventures

Our locations

Headquarters

333 Ravenswood Ave
Menlo Park, CA 94025 USA

+1 (650) 859-2000

Subscribe to our newsletter


日本支社
SRI International
  • Contact us
  • Privacy Policy
  • Cookies
  • DMCA
  • Copyright © 2022 SRI International